CD47 and neoplasm: pCAR-NPs work in situ on the “local” macrophage surrounding the postoperative tumor cavity, producing CAR-M there that targets the removal of glioma stem cells (GSCs); in the meantime, CD47 antibodies prevent tumors from sending the “do not eat me” signal.